HASHEM EL-SERAG to Humans
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Humans.
Connection Strength
5.011
-
A cluster randomized trial of a Multicomponent Clinical Care Pathway (MCCP) to improve MASLD diagnosis and management in primary care: study protocol. BMC Health Serv Res. 2025 May 06; 25(1):645.
Score: 0.026
-
Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct-Acting Antivirals Versus Interferon. Aliment Pharmacol Ther. 2025 Apr; 61(7):1226-1237.
Score: 0.026
-
Serum levels of total bile acids are associated with an increased risk of HCC in patients with cirrhosis. Hepatol Commun. 2024 Nov 01; 8(11).
Score: 0.025
-
HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States. Hepatology. 2025 Feb 01; 81(2):465-475.
Score: 0.025
-
PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk. Clin Gastroenterol Hepatol. 2024 Sep; 22(9):1858-1866.e4.
Score: 0.025
-
An Electronic Health Record Model for Predicting Risk of Hepatic Fibrosis in Primary Care Patients. Dig Dis Sci. 2024 Jul; 69(7):2430-2436.
Score: 0.025
-
Race/ethnicity and sex differences in the association between area-level arsenic exposure concentration and hepatocellular carcinoma (HCC) incidence rates in Texas. An ecological study. Environ Res. 2024 Jan 01; 240(Pt 2):117538.
Score: 0.024
-
Evolving Concepts in Helicobacter pylori Management. Gastroenterology. 2024 02; 166(2):267-283.
Score: 0.024
-
Concurrence of inflammatory bowel disease with multiple sclerosis or Hodgkin lymphoma. Eur J Gastroenterol Hepatol. 2023 12 01; 35(12):1349-1353.
Score: 0.024
-
Bioimpedance analysis predicts the etiology of cirrhosis in a prospective cohort study. Hepatol Commun. 2023 10 01; 7(10).
Score: 0.023
-
Gastric Cancer Risk in Patients with Long-Term Use of Proton Pump Inhibitors: A Systematic Review and Meta-Analysis of Observational and Interventional Studies. Dig Dis Sci. 2023 09; 68(9):3732-3744.
Score: 0.023
-
Association of Diet Quality with Metabolic (Dysfunction) Associated Fatty Liver Disease in Veterans in Primary Care. Nutrients. 2023 Jun 01; 15(11).
Score: 0.023
-
Opportunities to address gaps in early detection and improve outcomes of liver cancer. JNCI Cancer Spectr. 2023 05 02; 7(3).
Score: 0.023
-
Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2023 12; 21(13):3296-3304.e3.
Score: 0.023
-
Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference. Clin Gastroenterol Hepatol. 2023 08; 21(9):2183-2192.
Score: 0.023
-
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023 05; 20(5):338-349.
Score: 0.023
-
Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score. PLoS One. 2023; 18(2):e0282309.
Score: 0.023
-
Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology. 2023 03 01; 77(3):997-1005.
Score: 0.023
-
Why Has Screening and Surveillance for Barrett's Esophagus Fallen Short in Stemming the Rising Incidence of Esophageal Adenocarcinoma? Am J Gastroenterol. 2023 04 01; 118(4):590-592.
Score: 0.022
-
Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. Semin Liver Dis. 2023 02; 43(1):89-99.
Score: 0.022
-
Limits of the AGA Practice Update for Barrett's Esophagus Screening: A Proposal for Electronic Health Record-Adaptable Risk Models. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1963-1964.
Score: 0.022
-
Development and Validation of the Houston-BEST, a Barrett's Esophagus Risk Prediction Model Adaptable to Electronic Health Records. Clin Gastroenterol Hepatol. 2023 08; 21(9):2424-2426.e0.
Score: 0.022
-
Recent Decline in the Incidence of Hepatocellular Carcinoma in the United States. Clin Gastroenterol Hepatol. 2023 08; 21(9):2418-2420.e3.
Score: 0.022
-
The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting. Clin Gastroenterol Hepatol. 2023 05; 21(5):1252-1260.e5.
Score: 0.022
-
The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus. Clin Gastroenterol Hepatol. 2023 04; 21(4):1111-1113.e3.
Score: 0.021
-
The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States. Clin Gastroenterol Hepatol. 2023 02; 21(2):415-423.e4.
Score: 0.021
-
Why Do Small Intraductal Papillary Mucinous Neoplasms Create Such a Huge Management Challenge?: How International Classification of Diseases Codes Have Failed Us. Pancreas. 2022 02 01; 51(2):e13-e15.
Score: 0.021
-
External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans. Gastrointest Endosc. 2022 06; 95(6):1113-1122.
Score: 0.021
-
Associations of Duration, Intensity, and Quantity of Smoking With Risk of Gastric Intestinal Metaplasia. J Clin Gastroenterol. 2022 01 01; 56(1):e71-e76.
Score: 0.021
-
Rational HCC screening approaches for patients with NAFLD. J Hepatol. 2022 01; 76(1):195-201.
Score: 0.020
-
Risk for Post-Colonoscopy Irritable Bowel Syndrome in Patients With and Without Antibiotic Exposure: A Retrospective Cohort Study. Clin Gastroenterol Hepatol. 2022 06; 20(6):e1305-e1322.
Score: 0.020
-
Presentation of the AGA William Beaumont Prize in Gastroenterology to David Y. Graham, MD. Gastroenterology. 2021 07; 161(1):333-335.
Score: 0.020
-
Epidemiology of Hepatocellular Carcinoma. Hepatology. 2021 01; 73 Suppl 1:4-13.
Score: 0.019
-
Current Status of Chemoprevention in Barrett's Esophagus. Gastrointest Endosc Clin N Am. 2021 Jan; 31(1):117-130.
Score: 0.019
-
A multidisciplinary approach to improving transition readiness in pediatric liver transplant recipients. Pediatr Transplant. 2021 03; 25(2):e13839.
Score: 0.019
-
Histological assessment of gastric pseudopyloric metaplasia: Intra- and inter-observer consistency. Dig Liver Dis. 2021 01; 53(1):61-65.
Score: 0.019
-
European Registry on Helicobacter pylori management shows that gastroenterology has largely failed in its efforts to guide practitioners. Gut. 2021 01; 70(1):1-2.
Score: 0.019
-
Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-Based Cohort of Patients With Cirrhosis of Multiple Etiologies. Clin Gastroenterol Hepatol. 2021 07; 19(7):1443-1450.e6.
Score: 0.019
-
Prevalence of Barrett's esophagus and performance of societal?screening guidelines in an unreferred primary care population of U.S. veterans. Gastrointest Endosc. 2021 02; 93(2):409-419.e1.
Score: 0.019
-
Leadership During Crisis: Lessons and Applications from the COVID-19 Pandemic. Gastroenterology. 2020 09; 159(3):809-812.
Score: 0.019
-
Magnitude of and prediction for risk of hepatocellular carcinoma in patients with chronic hepatitis B taking entecavir or tenofovir therapy: A systematic review. J Gastroenterol Hepatol. 2020 Oct; 35(10):1684-1693.
Score: 0.019
-
Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA. Dig Dis Sci. 2021 03; 66(3):912-916.
Score: 0.019
-
Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort. Gastroenterology. 2020 07; 159(1):376-377.
Score: 0.018
-
Prevalence of Gastric Intestinal Metaplasia in a Multiethnic US Veterans Population. Clin Gastroenterol Hepatol. 2021 02; 19(2):269-276.e3.
Score: 0.018
-
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease. Hepatology. 2020 03; 71(3):808-819.
Score: 0.018
-
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review. Gastroenterology. 2020 05; 158(6):1822-1830.
Score: 0.018
-
Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents. Hepatology. 2020 01; 71(1):44-55.
Score: 0.018
-
Helicobacter pylori Infection. N Engl J Med. 2019 08 08; 381(6):587-588.
Score: 0.018
-
Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020 03; 18(3):534-542.
Score: 0.018
-
The Epidemiology of Hepatocellular Carcinoma in the USA. Curr Gastroenterol Rep. 2019 Apr 11; 21(4):17.
Score: 0.017
-
The effects of sustained virological response to direct-acting anti-viral therapy on the risk of extrahepatic manifestations of hepatitis C infection. Aliment Pharmacol Ther. 2019 06; 49(11):1442-1447.
Score: 0.017
-
Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study. Am J Gastroenterol. 2019 03; 114(3):530-532.
Score: 0.017
-
Reply. Clin Gastroenterol Hepatol. 2019 06; 17(7):1420.
Score: 0.017
-
Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality. Clin Gastroenterol Hepatol. 2019 09; 17(10):2117-2125.e3.
Score: 0.017
-
Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans With Cirrhosis. Clin Gastroenterol Hepatol. 2019 08; 17(9):1886-1893.e5.
Score: 0.017
-
Chemoprevention of Barrett's oesophagus: a step closer with PPIs and aspirin. Nat Rev Clin Oncol. 2018 12; 15(12):728-730.
Score: 0.017
-
Reply. Clin Gastroenterol Hepatol. 2018 12; 16(12):2004.
Score: 0.017
-
Reply. Clin Gastroenterol Hepatol. 2018 12; 16(12):2005-2006.
Score: 0.017
-
Changing Trends in Colorectal Cancers (Detected by Screening, During Screening Intervals, or Associated With Nonadherence) Identify Possible Health Care System Quality Measures. Gastroenterology. 2019 02; 156(3):809-811.
Score: 0.017
-
Epidemiology and Management of Hepatocellular Carcinoma. Gastroenterology. 2019 01; 156(2):477-491.e1.
Score: 0.017
-
Ancestry and Risk of Hepatic Fibrosis and Inflammation in Patients With HCV Infection. Clin Gastroenterol Hepatol. 2019 08; 17(9):1912-1914.
Score: 0.017
-
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology. 2018 12; 155(6):1828-1837.e2.
Score: 0.017
-
Hospitalizations for Chronic Liver Disease: Time to Intervene at Multiple Levels. Gastroenterology. 2018 09; 155(3):607-609.
Score: 0.016
-
Hepatocellular carcinoma screening is associated with survival benefit in silico but needs confirmation in an in vivo analysis. Hepatology. 2018 07; 68(1):7-9.
Score: 0.016
-
A Systematic Review of the Effectiveness of Psychological Treatments for IBS in Gastroenterology Settings: Promising but in Need of Further Study. Dig Dis Sci. 2018 09; 63(9):2189-2201.
Score: 0.016
-
How we approach it: treatment options for hepatocellular carcinoma. Am J Gastroenterol. 2018 06; 113(6):791-794.
Score: 0.016
-
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir. J Viral Hepat. 2018 05; 25(5):543-551.
Score: 0.016
-
Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. Clin Gastroenterol Hepatol. 2018 07; 16(7):992-1002.e6.
Score: 0.016
-
Editorial: NAFLD-related hepatocellular carcinoma - increasing or not? With or without cirrhosis? Aliment Pharmacol Ther. 2018 02; 47(3):437-438.
Score: 0.016
-
Evaluating screening approaches for hepatocellular carcinoma in a cohort of HCV related cirrhosis patients from the Veteran's Affairs Health Care System. BMC Med Res Methodol. 2018 01 04; 18(1):1.
Score: 0.016
-
Lessons From Using Culture-Guided Treatment After Referral for Multiple Treatment Failures for Helicobacter pylori Infection. Clin Gastroenterol Hepatol. 2018 09; 16(9):1531-1532.
Score: 0.016
-
Low-fat Dietary Pattern and Pancreatic Cancer Risk in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2018 01 01; 110(1).
Score: 0.016
-
Factors That Contribute to Indeterminate Results From the?QuantiFERON-TB Gold In-Tube Test in Patients With?Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2018 10; 16(10):1616-1621.e1.
Score: 0.016
-
The treatment path in hepatocellular carcinoma. Clin Adv Hematol Oncol. 2017 Aug; 15 Suppl 9(8):1-20.
Score: 0.015
-
Advances in the management of hepatocellular carcinoma. Clin Adv Hematol Oncol. 2017 Aug; 15 Suppl 9(8):2-6.
Score: 0.015
-
Endoscopic ablation of low-grade dysplasia in Barrett's?esophagus: Have all the boxes been checked for?us?to move on? Gastrointest Endosc. 2017 07; 86(1):130-132.
Score: 0.015
-
Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Cancer Control. 2017 Jul-Sep; 24(3):1073274817729245.
Score: 0.015
-
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents. Gastroenterology. 2017 10; 153(4):996-1005.e1.
Score: 0.015
-
Trends in 30-Day and 1-Year Mortality Among Patients Hospitalized With Cirrhosis From 2004 to 2013. Am J Gastroenterol. 2017 Aug; 112(8):1287-1297.
Score: 0.015
-
External Validation of the Michigan Barrett's Esophagus Prediction Tool. Clin Gastroenterol Hepatol. 2017 07; 15(7):1124-1126.
Score: 0.015
-
The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus. Am J Gastroenterol. 2017 Jul; 112(7):1049-1055.
Score: 0.015
-
Hepatocellular carcinoma surveillance: The road ahead. Hepatology. 2017 03; 65(3):771-773.
Score: 0.015
-
Clinical Manifestations of Helicobacter pylori-Negative Gastritis. Clin Gastroenterol Hepatol. 2017 Jul; 15(7):1037-1046.e3.
Score: 0.015
-
?Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study. Ann Hepatol. 2017 Jan-Feb 2017; 16(1):16-20.
Score: 0.015
-
The Top Five Reasons You Should Publish in Clinical Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2017 02; 15(2):164-165.
Score: 0.015
-
How to Prepare for and Write a Grant: Personal Perspectives. Gastroenterology. 2017 01; 152(1):7-11.
Score: 0.015
-
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. Gastroenterology. 2017 03; 152(4):812-820.e5.
Score: 0.015
-
Prediction Models for Gastrointestinal and Liver Diseases: Too Many Developed, Too Few Validated. Clin Gastroenterol Hepatol. 2016 12; 14(12):1678-1680.
Score: 0.014
-
Prevalence of Celiac Disease Among Unsuspected Patients Presenting to Open Access Endoscopy. Clin Gastroenterol Hepatol. 2017 01; 15(1):137-139.
Score: 0.014
-
Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance. Clin Gastroenterol Hepatol. 2017 02; 15(2):273-281.e1.
Score: 0.014
-
Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort. J Hepatol. 2016 12; 65(6):1148-1154.
Score: 0.014
-
Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis. Hepatology. 2016 08; 64(2):569-81.
Score: 0.014
-
Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology. 2016 07; 64(1):130-7.
Score: 0.014
-
Epidemiology and outcomes of hepatitis C infection in elderly US Veterans. J Viral Hepat. 2016 09; 23(9):687-96.
Score: 0.014
-
Curbside Consultations: The Good, the Bad, and the Ugly. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):2-4.
Score: 0.014
-
Is Proton Pump Inhibitor Use Associated With Risk of Myocardial Infarction? Gastroenterology. 2016 Feb; 150(2):526-7.
Score: 0.014
-
Sex and Racial Disparity in Incidence of Esophageal Adenocarcinoma: Observations and Explanations. Clin Gastroenterol Hepatol. 2016 Mar; 14(3):330-2.
Score: 0.014
-
The Updated Model: An Adjusted Serum Alpha-Fetoprotein-Based Algorithm for Hepatocellular Carcinoma Detection With Hepatitis C Virus-Related Cirrhosis. Gastroenterology. 2015 Dec; 149(7):1986-7.
Score: 0.014
-
Applying Lean Design Principles to a Gastrointestinal Endoscopy Program for Uninsured Patients Improves Health Care Utilization. Clin Gastroenterol Hepatol. 2015 Sep; 13(9):1556-9.e4.
Score: 0.013
-
The Art and Science of Managing Liver Disease. Clin Gastroenterol Hepatol. 2015 Nov; 13(12):2029-30.
Score: 0.013
-
Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus. Gut. 2016 08; 65(8):1252-60.
Score: 0.013
-
Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans. Clin Gastroenterol Hepatol. 2016 Feb; 14(2):301-8.e1-2.
Score: 0.013
-
Hepatocellular Carcinoma From Epidemiology to Prevention: Translating Knowledge into Practice. Clin Gastroenterol Hepatol. 2015 Nov; 13(12):2140-51.
Score: 0.013
-
Prevalence of Barrett's Esophagus in Asian Countries: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2015 Nov; 13(11):1907-18.
Score: 0.013
-
Statin use reduces risk of esophageal adenocarcinoma in US veterans with Barrett's esophagus: a nested case-control study. Gastroenterology. 2015 Nov; 149(6):1392-8.
Score: 0.013
-
Assessment of disease specific knowledge and health-related quality of life among United States military veterans with inflammatory bowel disease. World J Gastroenterol. 2015 May 21; 21(19):6001-7.
Score: 0.013
-
Lifestyle Intervention in Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol. 2016 Feb; 14(2):175-82.e1-3.
Score: 0.013
-
Esophageal carcinoma. N Engl J Med. 2015 04 09; 372(15):1472-3.
Score: 0.013
-
Metabolic syndrome and the risk of Barrett's oesophagus in white males. Aliment Pharmacol Ther. 2015 Jun; 41(11):1182-9.
Score: 0.013
-
Coffee and Caffeine Are Associated With Decreased Risk of Advanced Hepatic Fibrosis Among Patients With Hepatitis C. Clin Gastroenterol Hepatol. 2015 Aug; 13(8):1521-31.e3.
Score: 0.013
-
The Prevalence of Helicobacter pylori Remains High in African American and Hispanic Veterans. Helicobacter. 2015 Aug; 20(4):305-15.
Score: 0.013
-
Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection. Dig Dis Sci. 2015 Jul; 60(7):2030-7.
Score: 0.013
-
Esophageal carcinoma. N Engl J Med. 2014 Dec 25; 371(26):2499-509.
Score: 0.013
-
Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014 Dec; 109(12):1870-80.
Score: 0.013
-
The incidence of esophageal adenocarcinoma in a national veterans cohort with Barrett's esophagus. Am J Gastroenterol. 2014 Dec; 109(12):1862-8; quiz 1861, 1869.
Score: 0.013
-
Esophageal COX-2 expression is increased in Barrett's esophagus, obesity, and smoking. Dig Dis Sci. 2015 Jan; 60(1):65-73.
Score: 0.013
-
Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology. 2014 Nov; 60(5):1767-75.
Score: 0.013
-
Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans. Am J Gastroenterol. 2014 Sep; 109(9):1427-35.
Score: 0.012
-
Risk of upper gastrointestinal cancers in patients with gastroesophageal reflux disease after a negative screening endoscopy. Clin Gastroenterol Hepatol. 2015 Feb; 13(2):280-6.
Score: 0.012
-
Obesity and hepatocellular carcinoma: hype and reality. Hepatology. 2014 Sep; 60(3):779-81.
Score: 0.012
-
HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV. Hepatology. 2014 Jul; 60(1):98-105.
Score: 0.012
-
Decision aids for shared decision-making in Barrett's esophagus surveillance. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):91-3.
Score: 0.012
-
Statin use is associated with a decreased risk of Barrett's esophagus. Gastroenterology. 2014 Aug; 147(2):314-23.
Score: 0.012
-
Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1832-9.e6.
Score: 0.012
-
Brief report: the length of newly diagnosed Barrett's esophagus may be decreasing. Dis Esophagus. 2015 Jul; 28(5):418-21.
Score: 0.012
-
Hepatitis C virus treatment: the unyielding chasm between efficacy and effectiveness. Clin Gastroenterol Hepatol. 2014 Aug; 12(8):1381-3.
Score: 0.012
-
Use and yield of endoscopy in patients with uncomplicated gastroesophageal reflux disorder. JAMA Intern Med. 2014 Mar; 174(3):462-5.
Score: 0.012
-
Hepatology 2014: where are we going? Minerva Gastroenterol Dietol. 2014 Mar; 60(1):1-4.
Score: 0.012
-
Personal and family history of cancer and the risk of Barrett's esophagus in men. Dis Esophagus. 2015 Apr; 28(3):283-90.
Score: 0.012
-
A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis. Gastroenterology. 2014 May; 146(5):1249-55.e1.
Score: 0.012
-
A multibiomarker risk score helps predict risk for Barrett's esophagus. Clin Gastroenterol Hepatol. 2014 Aug; 12(8):1267-71.
Score: 0.012
-
Barrett's esophagus suspected at endoscopy but no specialized intestinal metaplasia on biopsy, what's next? Am J Gastroenterol. 2014 Feb; 109(2):178-82.
Score: 0.012
-
Poor sleep quality and obstructive sleep apnea in patients with GERD and Barrett's esophagus. Neurogastroenterol Motil. 2014 Mar; 26(3):346-52.
Score: 0.012
-
Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut. 2014 Aug; 63(8):1229-37.
Score: 0.012
-
No significant effects of smoking or alcohol consumption on risk of Barrett's esophagus. Dig Dis Sci. 2014 Jan; 59(1):108-16.
Score: 0.012
-
Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):327-333.e1.
Score: 0.012
-
Dietary consumption of meat, fat, animal products and advanced glycation end-products and the risk of Barrett's oesophagus. Aliment Pharmacol Ther. 2013 Oct; 38(7):817-24.
Score: 0.012
-
Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study. Clin Gastroenterol Hepatol. 2014 Feb; 12(2):229-238.e3.
Score: 0.012
-
Bundling in medicare patients undergoing bidirectional endoscopy: how often does it happen? Clin Gastroenterol Hepatol. 2014 Jan; 12(1):58-63.
Score: 0.012
-
Statins for chemoprevention of hepatocellular carcinoma: assessing the evidence. Expert Rev Gastroenterol Hepatol. 2013 Aug; 7(6):493-5.
Score: 0.012
-
Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey. Dig Dis Sci. 2013 Nov; 58(11):3117-26.
Score: 0.012
-
Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. Am J Gastroenterol. 2013 Oct; 108(10):1576-83.
Score: 0.012
-
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014 Jun; 63(6):871-80.
Score: 0.012
-
Dietary fructose intake and severity of liver disease in hepatitis C virus-infected patients. J Clin Gastroenterol. 2013 Jul; 47(6):545-52.
Score: 0.012
-
Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology. 2013 Aug; 58(2):538-45.
Score: 0.012
-
Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol. 2013 Jul; 47 Suppl:S2-6.
Score: 0.012
-
The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males. Aliment Pharmacol Ther. 2013 Jul; 38(1):28-37.
Score: 0.012
-
Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013 Jun; 108(6):915-22.
Score: 0.011
-
The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study. Inflamm Bowel Dis. 2013 Apr; 19(5):1059-64.
Score: 0.011
-
Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors. Hepatology. 2013 May; 57(5):1858-68.
Score: 0.011
-
CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. Gastroenterology. 2013 Mar; 144(3):478-81.
Score: 0.011
-
CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):200-3.
Score: 0.011
-
The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy. Aliment Pharmacol Ther. 2013 Apr; 37(8):825-32.
Score: 0.011
-
Dietary intake of vegetables, folate, and antioxidants and the risk of Barrett's esophagus. Cancer Causes Control. 2013 May; 24(5):1005-14.
Score: 0.011
-
Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett's oesophagus: a case-control study. Gut. 2014 Feb; 63(2):220-9.
Score: 0.011
-
Occupational exposure and the risk of Barrett's esophagus: a case-control study. Dig Dis Sci. 2013 Jul; 58(7):1967-75.
Score: 0.011
-
a-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):441-3.
Score: 0.011
-
Sleep duration and incidence of colorectal cancer in postmenopausal women. Br J Cancer. 2013 Jan 15; 108(1):213-21.
Score: 0.011
-
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):373-381.e1.
Score: 0.011
-
Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol. 2013 Jan; 108(1):65-71.
Score: 0.011
-
Automated identification of surveillance colonoscopy in inflammatory bowel disease using natural language processing. Dig Dis Sci. 2013 Apr; 58(4):936-41.
Score: 0.011
-
Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit. Aliment Pharmacol Ther. 2012 Dec; 36(11-12):1049-56.
Score: 0.011
-
Surveillance for hepatocellular carcinoma: long way to achieve effectiveness. Dig Dis Sci. 2012 Dec; 57(12):3050-1.
Score: 0.011
-
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol. 2012 Dec; 10(12):1342-1359.e2.
Score: 0.011
-
Racial differences in the association between adiposity measures and the risk of hepatitis C-related liver disease. J Clin Gastroenterol. 2012 Oct; 46(9):779-88.
Score: 0.011
-
Practice patterns of surveillance endoscopy in a Veterans Affairs database of 29,504 patients with Barrett's esophagus. Gastrointest Endosc. 2012 Oct; 76(4):743-55.
Score: 0.011
-
Postreferral colonoscopy delays in diagnosis of colorectal cancer: a mixed-methods analysis. Qual Manag Health Care. 2012 Oct-Dec; 21(4):252-61.
Score: 0.011
-
Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy. BMC Health Serv Res. 2012 Aug 28; 12:288.
Score: 0.011
-
Human papillomavirus and the risk of Barrett's esophagus. Dis Esophagus. 2013 Jul; 26(5):517-21.
Score: 0.011
-
Natural history of pediatric-onset inflammatory bowel disease: a systematic review. J Clin Gastroenterol. 2012 Aug; 46(7):581-9.
Score: 0.011
-
The new board of editors for clinical gastroenterology and hepatology: our vision and plans. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):690-1.
Score: 0.011
-
Finasteride and methadone use and risk of advanced hepatitis C related liver disease. Dig Dis Sci. 2012 Nov; 57(11):3004-10.
Score: 0.011
-
Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012 May; 142(6):1264-1273.e1.
Score: 0.011
-
The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. Gastroenterology. 2012 Jul; 143(1):70-7.
Score: 0.011
-
The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter. 2012 Jun; 17(3):163-75.
Score: 0.011
-
Expression of androgen receptors in Barrett esophagus. J Clin Gastroenterol. 2012 Mar; 46(3):251-2.
Score: 0.011
-
Utilization and outcomes of palliative therapy for hepatocellular carcinoma: a population-based study in the United States. J Clin Gastroenterol. 2012 Jan; 46(1):71-7.
Score: 0.010
-
Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology. 2012 Mar; 55(3):759-68.
Score: 0.010
-
Determinants of serum alpha-fetoprotein levels in hepatitis C-infected patients. Clin Gastroenterol Hepatol. 2012 Apr; 10(4):428-33.
Score: 0.010
-
Hepatocellular carcinoma. N Engl J Med. 2011 Sep 22; 365(12):1118-27.
Score: 0.010
-
Risk of colorectal cancer among Caucasian and African American veterans with ulcerative colitis. Inflamm Bowel Dis. 2012 Jun; 18(6):1011-7.
Score: 0.010
-
Level of a-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011 Nov; 9(11):989-94.
Score: 0.010
-
Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2011 Sep; 34(6):618-27.
Score: 0.010
-
Gaps in the achievement of effectiveness of HCV treatment in national VA practice. J Hepatol. 2012 Feb; 56(2):320-5.
Score: 0.010
-
Risk factors for cholangiocarcinoma. Hepatology. 2011 Jul; 54(1):173-84.
Score: 0.010
-
Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011 Apr; 106(4):563-73.
Score: 0.010
-
Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia. Aliment Pharmacol Ther. 2011 Apr; 33(7):829-36.
Score: 0.010
-
The influence of age, sex, and race on the incidence of esophageal cancer in the United States (1992-2006). Scand J Gastroenterol. 2011 May; 46(5):597-602.
Score: 0.010
-
Effectiveness of AFP and ultrasound tests on hepatocellular carcinoma mortality in HCV-infected patients in the USA. Gut. 2011 Jul; 60(7):992-7.
Score: 0.010
-
Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Ann Intern Med. 2011 Jan 18; 154(2):85-93.
Score: 0.010
-
Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection. Dig Dis Sci. 2011 Jun; 56(6):1835-47.
Score: 0.010
-
Alpha-fetoprotein should be included in the hepatocellular carcinoma surveillance guidelines of the American Association for the Study of Liver Diseases. Hepatology. 2011 Mar; 53(3):1060-1; author reply 1061-2.
Score: 0.010
-
Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology. 2011 Apr; 140(4):1182-1188.e1.
Score: 0.010
-
Routine polypectomy for colorectal polyps and ablation for Barrett's esophagus are intellectually the same. Gastroenterology. 2011 Feb; 140(2):386-8.
Score: 0.010
-
Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection. Hepatology. 2011 Jan; 53(1):42-52.
Score: 0.010
-
Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study. Am J Gastroenterol. 2011 Mar; 106(3):483-91.
Score: 0.010
-
Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data. Dig Dis Sci. 2010 Nov; 55(11):3241-51.
Score: 0.010
-
Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther. 2010 Sep; 32(6):720-37.
Score: 0.010
-
Systematic review: the epidemiology of eosinophilic oesophagitis in adults. Aliment Pharmacol Ther. 2010 Sep; 32(6):712-9.
Score: 0.010
-
Efficacy, effectiveness, and comparative effectiveness in liver disease. Hepatology. 2010 Aug; 52(2):403-7.
Score: 0.009
-
The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis. 2010 Jul; 42 Suppl 3:S206-14.
Score: 0.009
-
Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology. 2010 Jul; 52(1):132-41.
Score: 0.009
-
Reducing referral delays in colorectal cancer diagnosis: is it about how you ask? Qual Saf Health Care. 2010 Oct; 19(5):e27.
Score: 0.009
-
Trauma history and risk of the irritable bowel syndrome in women veterans. Aliment Pharmacol Ther. 2010 Aug; 32(4):551-61.
Score: 0.009
-
Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Dig Dis Sci. 2010 Dec; 55(12):3404-7.
Score: 0.009
-
Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease. J Fam Pract. 2010 Apr; 59(4 Suppl):S37-42.
Score: 0.009
-
Gastroesophageal reflux and asthma in children: a systematic review. Pediatrics. 2010 Apr; 125(4):e925-30.
Score: 0.009
-
Underdiagnosis of Lynch syndrome involves more than family history criteria. Clin Gastroenterol Hepatol. 2010 Jun; 8(6):523-9.
Score: 0.009
-
The epidemiology of obesity. Gastroenterol Clin North Am. 2010 Mar; 39(1):1-7.
Score: 0.009
-
Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology. 2010 Jun; 138(7):2260-6.
Score: 0.009
-
The dawn of a new era: transforming our domestic response to hepatitis B & C. Gastroenterology. 2010 Apr; 138(4):1225-30, 1230.e1-3.
Score: 0.009
-
Statin therapy and serum transaminases among a cohort of HCV-infected veterans. Dig Dis Sci. 2010 Jan; 55(1):190-5.
Score: 0.009
-
Irritable bowel syndrome symptoms and health related quality of life in female veterans. Aliment Pharmacol Ther. 2010 Jan 15; 31(2):261-73.
Score: 0.009
-
Surveillance in Barrett's esophagus: lessons from behavioral economics. Gastroenterology. 2009 Sep; 137(3):763-5.
Score: 0.009
-
Diagnostic yield of oesophagogastroduodenoscopy in children with abdominal pain. Aliment Pharmacol Ther. 2009 Sep 15; 30(6):662-9.
Score: 0.009
-
The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. Am J Gastroenterol. 2009 Sep; 104(9):2161-7.
Score: 0.009
-
The big burden of obesity. Gastrointest Endosc. 2009 Oct; 70(4):752-7.
Score: 0.009
-
Missed opportunities to initiate endoscopic evaluation for colorectal cancer diagnosis. Am J Gastroenterol. 2009 Oct; 104(10):2543-54.
Score: 0.009
-
Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma. Minerva Gastroenterol Dietol. 2009 Jun; 55(2):123-38.
Score: 0.009
-
Systematic review: the global incidence and prevalence of peptic ulcer disease. Aliment Pharmacol Ther. 2009 May 01; 29(9):938-46.
Score: 0.009
-
The utility of evaluating low serum albumin gradient ascites in patients with cirrhosis. Am J Gastroenterol. 2009 Jun; 104(6):1401-5.
Score: 0.009
-
Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol. 2009 May; 104(5):1241-8.
Score: 0.009
-
Alcohol drinking and the risk of Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 2009 Apr; 136(4):1155-7.
Score: 0.009
-
Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Dis Esophagus. 2009; 22(7):571-87.
Score: 0.009
-
Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009 May; 136(5):1601-8.
Score: 0.009
-
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology. 2009 Jan; 49(1):116-23.
Score: 0.008
-
Gene expression in Barrett's esophagus: laser capture versus whole tissue. Scand J Gastroenterol. 2009; 44(7):787-95.
Score: 0.008
-
Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database. Aliment Pharmacol Ther. 2009 Mar 01; 29(5):470-80.
Score: 0.008
-
Hepatocellular cancer care: cost is important but only one factor of disease burden. J Hepatol. 2009 Jan; 50(1):10-2.
Score: 0.008
-
Epidemiology of non-erosive reflux disease. Digestion. 2008; 78 Suppl 1:6-10.
Score: 0.008
-
Irritable bowel syndrome and dyspepsia among women veterans: prevalence and association with psychological distress. Aliment Pharmacol Ther. 2009 Jan; 29(1):115-25.
Score: 0.008
-
Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol. 2008 Nov; 49(5):831-44.
Score: 0.008
-
Hepatitis vaccination in patients with hepatitis C: practice and validation of codes at a large Veterans Administration Medical Centre. Aliment Pharmacol Ther. 2008 Nov 01; 28(9):1078-87.
Score: 0.008
-
Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008 Nov 01; 28(9):1166-74.
Score: 0.008
-
The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008 Sep; 53(9):2307-12.
Score: 0.008
-
Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008 May; 134(6):1752-63.
Score: 0.008
-
Prevalence and histological features of the gastric cardia-type mucosa in children. Dig Dis Sci. 2008 Jul; 53(7):1792-6.
Score: 0.008
-
The use of acid-decreasing medication in veteran patients with gastro-oesophageal reflux disorder with and without Barrett's oesophagus. Aliment Pharmacol Ther. 2008 Jun; 27(12):1293-9.
Score: 0.008
-
Role of obesity in GORD-related disorders. Gut. 2008 Mar; 57(3):281-4.
Score: 0.008
-
Genetic association studies: from "searching under the lamppost" to "fishing in the pond". Gastroenterology. 2008 Mar; 134(3):662-4.
Score: 0.008
-
Manuscript writing. Gastrointest Endosc. 2008 Feb; 67(2):311-2.
Score: 0.008
-
Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol. 2008 Jan 20; 26(3):474-9.
Score: 0.008
-
Mortality associated with gastroesophageal reflux disease and its non-malignant complications: a systematic review. Scand J Gastroenterol. 2008; 43(6):645-53.
Score: 0.008
-
Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol. 2008 Feb 15; 167(4):377-89.
Score: 0.008
-
Hepatitis C infection: dying with or from the infection? J Hepatol. 2008 Feb; 48(2):183-4.
Score: 0.008
-
The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther. 2008 Feb 01; 27(3):274-82.
Score: 0.008
-
Effect of human immunodeficiency virus and antiretrovirals on outcomes of hepatitis C: a systematic review from an epidemiologic perspective. Clin Gastroenterol Hepatol. 2007 Nov; 5(11):1321-1328.e7.
Score: 0.008
-
Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based study. J Clin Gastroenterol. 2007 Nov-Dec; 41(10):911-7.
Score: 0.008
-
Epidemiology of hepatocellular carcinoma in Hispanics in the United States. Arch Intern Med. 2007 Oct 08; 167(18):1983-9.
Score: 0.008
-
Prevalence and determinants of histological abnormalities of the gastric cardia in volunteers. Scand J Gastroenterol. 2007 Oct; 42(10):1158-66.
Score: 0.008
-
Utilization of screening for hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2007 Sep; 41(8):777-82.
Score: 0.008
-
The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut. 2007 Dec; 56(12):1654-64.
Score: 0.008
-
Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States. Ann Surg Oncol. 2007 Sep; 14(9):2519-27.
Score: 0.008
-
Determinants of gastroesophageal reflux disease in adults with a history of childhood gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2007 Jun; 5(6):696-701.
Score: 0.008
-
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007 Jun; 132(7):2557-76.
Score: 0.008
-
Temporal trends in new and recurrent oesophageal strictures in a Medicare population. Aliment Pharmacol Ther. 2007 May 15; 25(10):1223-9.
Score: 0.008
-
Oral contraception and the risk of hepatocellular carcinoma. J Hepatol. 2007 Oct; 47(4):506-13.
Score: 0.008
-
The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study. Am J Gastroenterol. 2007 Jul; 102(7):1377-82.
Score: 0.008
-
The use of cytokeratin stain to distinguish Barrett's esophagus from contiguous tissues: a systematic review. Dig Dis Sci. 2007 May; 52(5):1345-54.
Score: 0.007
-
Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr. 2007 Mar; 150(3):262-7, 267.e1.
Score: 0.007
-
Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther. 2007 Jan 15; 25(2):143-53.
Score: 0.007
-
GI Epidemiology: databases for epidemiological studies. Aliment Pharmacol Ther. 2007 Jan 15; 25(2):169-76.
Score: 0.007
-
Translational research: the study of community effectiveness in digestive and liver disorders. Gastroenterology. 2007 Jan; 132(1):8-10.
Score: 0.007
-
Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007 Jan; 5(1):17-26.
Score: 0.007
-
Scientific manuscripts: the fun of writing and submitting. Gastrointest Endosc. 2006 Dec; 64(6 Suppl):S19-22.
Score: 0.007
-
Obesity increases oesophageal acid exposure. Gut. 2007 Jun; 56(6):749-55.
Score: 0.007
-
The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs. Arch Intern Med. 2006 Nov 13; 166(20):2202-8.
Score: 0.007
-
The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study. Gastrointest Endosc. 2006 Nov; 64(5):671-5.
Score: 0.007
-
Noncardia gastric adenocarcinoma remains an important and deadly cancer in the United States: secular trends in incidence and survival. Am J Gastroenterol. 2006 Nov; 101(11):2485-92.
Score: 0.007
-
Anthropometric correlates of intragastric pressure. Scand J Gastroenterol. 2006 Aug; 41(8):887-91.
Score: 0.007
-
The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther. 2006 Jul 01; 24(1):87-94.
Score: 0.007
-
Is genomic evaluation feasible in endoscopic studies of Barrett's esophagus? A pilot study. Gastrointest Endosc. 2006 Jul; 64(1):17-26.
Score: 0.007
-
Temporal trends in new and recurrent esophageal strictures in Department of Veterans Affairs. Am J Gastroenterol. 2006 Aug; 101(8):1727-33.
Score: 0.007
-
A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev. 2006 Jun; 15(6):1198-203.
Score: 0.007
-
Is there a race-based disparity in the survival of veterans with HIV? J Gen Intern Med. 2006 Jun; 21(6):613-7.
Score: 0.007
-
The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006 Mar; 4(3):369-80.
Score: 0.007
-
Racial differences in survival of hepatocellular carcinoma in the United States: a population-based study. Clin Gastroenterol Hepatol. 2006 Jan; 4(1):104-10; quiz 4-5.
Score: 0.007
-
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study. J Hepatol. 2006 Jan; 44(1):158-66.
Score: 0.007
-
Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol. 2005 Oct; 100(10):2151-6.
Score: 0.007
-
Physical and psychosocial contributors to quality of life in veterans with hepatitis C not on antiviral therapy. J Clin Gastroenterol. 2005 Sep; 39(8):731-6.
Score: 0.007
-
Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction. Dig Dis Sci. 2005 Sep; 50(9):1722-8.
Score: 0.007
-
Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005 Aug 02; 143(3):199-211.
Score: 0.007
-
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol. 2005 Jun; 100(6):1243-50.
Score: 0.007
-
Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol. 2005 May; 100(5):1002-8.
Score: 0.007
-
Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut. 2005 Apr; 54(4):533-9.
Score: 0.007
-
Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era. J Hepatol. 2005 Mar; 42(3):309-14.
Score: 0.007
-
Obesity and disease of the esophagus and colon. Gastroenterol Clin North Am. 2005 Mar; 34(1):63-82.
Score: 0.007
-
Impact of an Electronic Medical Record Quality Improvement Intervention on Helicobacter pylori Treatment and Eradication Rates in a U.S. Hospital System. Helicobacter. 2025 Mar-Apr; 30(2):e70034.
Score: 0.007
-
Dairy Consumption and the Colonic Mucosa-Associated Gut Microbiota in Humans-A Preliminary Investigation. Nutrients. 2025 Feb 02; 17(3).
Score: 0.006
-
Management of the single liver nodule in a cirrhotic patient: a decision analysis model. J Clin Gastroenterol. 2005 Feb; 39(2):152-9.
Score: 0.006
-
Utility of a depression score to predict candidacy for hepatitis C virus therapy in veterans: a prospective longitudinal study. Aliment Pharmacol Ther. 2005 Feb 01; 21(3):235-42.
Score: 0.006
-
Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans. Clin Gastroenterol Hepatol. 2005 Feb; 3(2):175-83.
Score: 0.006
-
Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut. 2005 Jan; 54(1):11-7.
Score: 0.006
-
Increased use of low anterior resection for veterans with rectal cancer. Aliment Pharmacol Ther. 2005 Jan 01; 21(1):35-41.
Score: 0.006
-
Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005 Jan; 146(1):35-40.
Score: 0.006
-
The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol. 2005 Jan; 100(1):56-63.
Score: 0.006
-
The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 2005 Jan; 100(1):162-8.
Score: 0.006
-
Prevalence and Outcomes of Emergency Presentations of Colorectal Cancer in Veterans Affairs Health Care System. Dig Dis Sci. 2025 Jan; 70(1):177-190.
Score: 0.006
-
Interval Advanced Adenomas and Neoplasia in Patients with Negative Colonoscopy Following Positive Stool-Based Colorectal Cancer Screening Test. Dig Dis Sci. 2025 Jan; 70(1):350-359.
Score: 0.006
-
Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med. 2004 Nov 22; 164(21):2349-54.
Score: 0.006
-
Outcomes in elderly patients following surgery for colorectal cancer in the veterans affairs health care system. Aliment Pharmacol Ther. 2004 Nov 15; 20(10):1115-24.
Score: 0.006
-
Phase 3 Validation of PAaM for Hepatocellular Carcinoma Risk Stratification in Cirrhosis. Gastroenterology. 2025 Mar; 168(3):556-567.e7.
Score: 0.006
-
Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004 Nov; 127(5 Suppl 1):S27-34.
Score: 0.006
-
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology. 2004 Nov; 127(5):1372-80.
Score: 0.006
-
Outcomes of surgical fundoplication in children. Clin Gastroenterol Hepatol. 2004 Nov; 2(11):978-84.
Score: 0.006
-
The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol. 2004 Nov; 99(11):2210-6.
Score: 0.006
-
GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. JAMA Intern Med. 2024 Nov 01; 184(11):1314-1323.
Score: 0.006
-
Neighborhood-level deprivation mediates racial and ethnic disparities in HCC diagnosis in Texas. Hepatol Commun. 2024 Nov 01; 8(11).
Score: 0.006
-
Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus. Am J Gastroenterol. 2004 Oct; 99(10):1877-83.
Score: 0.006
-
The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines. Gut. 2024 Sep 09; 73(10):1607-1617.
Score: 0.006
-
Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C. J Clin Gastroenterol. 2004 Jul; 38(6):530-4.
Score: 0.006
-
The length of newly diagnosed Barrett's oesophagus and prior use of acid suppressive therapy. Aliment Pharmacol Ther. 2004 Jun 15; 19(12):1255-60.
Score: 0.006
-
Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004 Jun; 126(7):1692-9.
Score: 0.006
-
Childhood GERD is a risk factor for GERD in adolescents and young adults. Am J Gastroenterol. 2004 May; 99(5):806-12.
Score: 0.006
-
The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004 May; 24(2):115-25.
Score: 0.006
-
Systemic review: Natural history of irritable bowel syndrome. Aliment Pharmacol Ther. 2004 Apr 15; 19(8):861-70.
Score: 0.006
-
Is the length of newly diagnosed Barrett's esophagus decreasing? The experience of a VA Health Care System. Clin Gastroenterol Hepatol. 2004 Apr; 2(4):296-300.
Score: 0.006
-
Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System. Am J Gastroenterol. 2004 Apr; 99(4):668-75.
Score: 0.006
-
Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004 Mar 15; 19(6):643-54.
Score: 0.006
-
Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology. 2004 Mar; 39(3):798-803.
Score: 0.006
-
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004 Mar; 40(3):472-7.
Score: 0.006
-
RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates. Gut. 2024 02 23; 73(3):407-441.
Score: 0.006
-
Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Hepatology. 2024 07 01; 80(1):87-101.
Score: 0.006
-
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology. 2004 Feb; 126(2):460-8.
Score: 0.006
-
Recent Trends in the Incidence of Gastric Cancer in the United States. J Clin Gastroenterol. 2024 01 01; 58(1):39-45.
Score: 0.006
-
Emergency Presentations Predict Worse Outcomes Among Patients with Pancreatic Cancer. Dig Dis Sci. 2024 Feb; 69(2):603-614.
Score: 0.006
-
A Practical Guide to Evaluating and Using Big Data in Digestive Disease Research. Gastroenterology. 2024 02; 166(2):240-247.
Score: 0.006
-
The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003 Nov 18; 139(10):817-23.
Score: 0.006
-
The Impact of Race on Pancreatic Cancer Treatment and Survival in the Nationwide Veterans Affairs Healthcare System. Pancreas. 2024 Jan 01; 53(1):e27-e33.
Score: 0.006
-
The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? Am J Gastroenterol. 2003 Nov; 98(11):2535-42.
Score: 0.006
-
Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther. 2003 Aug 15; 18(4):387-93.
Score: 0.006
-
Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System. Dig Dis Sci. 2023 09; 68(9):3634-3643.
Score: 0.006
-
Improving Adherence to Clinical Practice Guidelines for Managing Gastric Intestinal Metaplasia Among Gastroenterologists at a US Academic Institution. J Clin Gastroenterol. 2024 May-Jun 01; 58(5):432-439.
Score: 0.006
-
Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol. 2003 Jul; 98(7):1627-33.
Score: 0.006
-
Is there a true "shift" to the right colon in the incidence of colorectal cancer? Am J Gastroenterol. 2003 Jun; 98(6):1400-9.
Score: 0.006
-
Validation of a pre-endoscopy risk score for predicting the presence of gastric intestinal metaplasia in a U.S. population. Gastrointest Endosc. 2023 10; 98(4):569-576.e1.
Score: 0.006
-
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2003 May 15; 17(10):1229-36.
Score: 0.006
-
Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol. 2003 May; 98(5):1186-92.
Score: 0.006
-
Geographic variation within the United States in the incidence of hepatocellular carcinoma. J Clin Epidemiol. 2003 May; 56(5):487-93.
Score: 0.006
-
The Association between Caffeine Intake and the Colonic Mucosa-Associated Gut Microbiota in Humans-A Preliminary Investigation. Nutrients. 2023 Apr 03; 15(7).
Score: 0.006
-
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment. Nat Rev Gastroenterol Hepatol. 2023 08; 20(8):487-503.
Score: 0.006
-
Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol. 2003 Jan; 98(1):167-74.
Score: 0.006
-
Impact of irritable bowel syndrome: prevalence and effect on health-related quality of life. Rev Gastroenterol Disord. 2003; 3 Suppl 2:S3-11.
Score: 0.006
-
Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002 Dec; 36(6):1439-45.
Score: 0.006
-
Cholangiocarcinoma: the "other" liver cancer on the rise. Am J Gastroenterol. 2002 Dec; 97(12):3199-200.
Score: 0.006
-
Longitudinal changes in fibrosis markers are associated with risk of cirrhosis and hepatocellular carcinoma in non-alcoholic fatty liver disease. J Hepatol. 2023 03; 78(3):493-500.
Score: 0.006
-
Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002 Nov-Dec; 35(5 Suppl 2):S72-8.
Score: 0.006
-
Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002 Nov; 36(5 Suppl 1):S74-83.
Score: 0.006
-
Prevalence and risk factors of nonalcoholic fatty liver disease in a general population, the HUNT study. Scand J Gastroenterol. 2023 05; 58(5):505-511.
Score: 0.006
-
Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy. J Gastroenterol. 2022 12; 57(12):942-951.
Score: 0.006
-
The Predictive Performance of Contemporary Guideline Recommendations for Helicobacter pylori Testing in a United States Population. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1771-1780.
Score: 0.006
-
Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med. 2002 Oct 14; 162(18):2105-10.
Score: 0.006
-
NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity? Semin Liver Dis. 2022 11; 42(4):465-474.
Score: 0.006
-
Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality. JAMA Netw Open. 2022 10 03; 5(10):e2234221.
Score: 0.006
-
Surveillance for hepatocellular carcinoma: does it work? Am J Gastroenterol. 2002 Oct; 97(10):2676-7.
Score: 0.006
-
Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionals. Cancer Med. 2023 02; 12(3):3670-3683.
Score: 0.005
-
Using Natural Language Processing to Automatically Identify Dysplasia in Pathology Reports for Patients With Barrett's Esophagus. Clin Gastroenterol Hepatol. 2023 05; 21(5):1198-1204.
Score: 0.005
-
Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2002 Sep; 35(3):266-9.
Score: 0.005
-
Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection. Am J Gastroenterol. 2022 11 01; 117(11):1834-1844.
Score: 0.005
-
Neighborhood-Level Factors Contribute to Disparities in Hepatocellular Carcinoma Incidence in Texas. Clin Gastroenterol Hepatol. 2023 05; 21(5):1314-1322.e5.
Score: 0.005
-
Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002 Aug; 123(2):476-82.
Score: 0.005
-
Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2002 Aug; 37(8):899-904.
Score: 0.005
-
Contemporary Changes in Etiology for Hepatocellular Carcinoma in Liver Transplantation. Clin Gastroenterol Hepatol. 2023 08; 21(9):2410-2412.e1.
Score: 0.005
-
Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes. Dig Dis Sci. 2023 01; 68(1):312-322.
Score: 0.005
-
Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002 Jul; 36(1):227-42.
Score: 0.005
-
Endoscopic manifestations of gastroesophageal reflux disease in patients between 18 months and 25 years without neurological deficits. Am J Gastroenterol. 2002 Jul; 97(7):1635-9.
Score: 0.005
-
Mediating Effects of Neighborhood-Level Socioeconomic Deprivation on the Association Between Race/Ethnicity and Advanced Hepatocellular Carcinoma. Cancer Epidemiol Biomarkers Prev. 2022 07 01; 31(7):1402-1409.
Score: 0.005
-
Dietary Fatty Acid Intake and the Colonic Gut Microbiota in Humans. Nutrients. 2022 Jun 29; 14(13).
Score: 0.005
-
Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC). Dig Dis Sci. 2023 03; 68(3):1060-1070.
Score: 0.005
-
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight. Nat Rev Gastroenterol Hepatol. 2022 10; 19(10):638-651.
Score: 0.005
-
Missed Opportunities for Screening or Surveillance Among Patients with Newly Diagnosed Non-cardia Gastric Adenocarcinoma. Dig Dis Sci. 2023 03; 68(3):761-769.
Score: 0.005
-
Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis. Clin Gastroenterol Hepatol. 2023 04; 21(4):1023-1030.e39.
Score: 0.005
-
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022 07 05; 34(7):969-977.e2.
Score: 0.005
-
Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther. 2002 Jun; 16(6):1171-85.
Score: 0.005
-
Diabetes increases the risk of acute hepatic failure. Gastroenterology. 2002 Jun; 122(7):1822-8.
Score: 0.005
-
The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am. 2002 Jun; 31(2):421-40, viii.
Score: 0.005
-
Inverse Association Between Gluteofemoral Obesity and Risk of Non-Cardia Gastric Intestinal Metaplasia. Clin Gastroenterol Hepatol. 2023 01; 21(1):64-71.
Score: 0.005
-
Perceptions of weight status and energy balance behaviors among patients with non-alcoholic fatty liver disease. Sci Rep. 2022 04 05; 12(1):5695.
Score: 0.005
-
Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut. 2002 Mar; 50(3):368-72.
Score: 0.005
-
Comparative Effectiveness of Surveillance Colonoscopy Intervals on Colorectal Cancer Outcomes in a National Cohort of Patients with Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2022 12; 20(12):2848-2857.e2.
Score: 0.005
-
Race/Ethnicity and Birthplace as Risk Factors for Gastric Intestinal Metaplasia in a Multiethnic United States Population. Am J Gastroenterol. 2022 02 01; 117(2):280-287.
Score: 0.005
-
Treatment of hepatitis C virus infection in people with opioid use disorder: a real-world study of elbasvir/grazoprevir in a US Department of Veterans Affairs population. Am J Drug Alcohol Abuse. 2022 07 04; 48(4):445-453.
Score: 0.005
-
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2022 05; 75(5):1289-1299.
Score: 0.005
-
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease. Hepatology. 2022 06; 75(6):1420-1428.
Score: 0.005
-
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis. Hepatology. 2022 03; 75(3):541-549.
Score: 0.005
-
Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology. 2001 Dec; 121(6):1294-9.
Score: 0.005
-
Interferon: benefit beyond hepatitis therapy? Am J Gastroenterol. 2001 Dec; 96(12):3435-6.
Score: 0.005
-
Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population. Dig Dis Sci. 2022 09; 67(9):4500-4508.
Score: 0.005
-
Alcohol consumption and the risk of gastric intestinal metaplasia in a U.S. Veterans population. PLoS One. 2021; 16(11):e0260019.
Score: 0.005
-
Artificial intelligence in gastroenterology: A state-of-the-art review. World J Gastroenterol. 2021 Oct 28; 27(40):6794-6824.
Score: 0.005
-
Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States. J Hepatol. 2022 02; 76(2):294-301.
Score: 0.005
-
Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2021 11; 161(5):1657-1669.
Score: 0.005
-
Preparing for the NASH epidemic: A call to action. Obesity (Silver Spring). 2021 09; 29(9):1401-1412.
Score: 0.005
-
The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol. 2001 Aug; 96(8):2462-7.
Score: 0.005
-
Gastro-oesophageal reflux disease. Nat Rev Dis Primers. 2021 07 29; 7(1):55.
Score: 0.005
-
Preparing for the NASH Epidemic: A Call to Action. Diabetes Care. 2021 09; 44(9):2162-2172.
Score: 0.005
-
Preparing for the NASH Epidemic: A Call to Action. Gastroenterology. 2021 09; 161(3):1030-1042.e8.
Score: 0.005
-
Preparing for the NASH epidemic: A call to action. Metabolism. 2021 09; 122:154822.
Score: 0.005
-
A Conceptual Model for Implementation and Evaluation of Interventions Across the Hepatocellular Carcinoma Care Continuum. Clin Gastroenterol Hepatol. 2022 05; 20(5):1174-1176.
Score: 0.005
-
Spatial Characteristics of Colonic Mucosa-Associated Gut Microbiota in Humans. Microb Ecol. 2022 Apr; 83(3):811-821.
Score: 0.005
-
Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol. 2001 Jul; 96(7):2013-8.
Score: 0.005
-
Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis. Am J Gastroenterol. 2001 Jul; 96(7):2206-10.
Score: 0.005
-
Prevalence and Predictors of Missed Dysplasia on Index Barrett's Esophagus Diagnosing Endoscopy in a Veteran Population. Clin Gastroenterol Hepatol. 2022 04; 20(4):e876-e889.
Score: 0.005
-
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol. 2001 Apr; 96(4):979-83.
Score: 0.005
-
A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis. Cancer Prev Res (Phila). 2021 06; 14(6):667-674.
Score: 0.005
-
Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001 Feb; 5(1):87-107, vi.
Score: 0.005
-
Predictors of five-year survival among patients with hepatocellular carcinoma in the United States: an analysis of SEER-Medicare. Cancer Causes Control. 2021 Apr; 32(4):317-325.
Score: 0.005
-
Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology. 2001 Jan; 33(1):62-5.
Score: 0.005
-
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021 04; 18(4):223-238.
Score: 0.005
-
Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol. 2000 Dec; 95(12):3566-73.
Score: 0.005
-
Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med. 2000 Nov 27; 160(21):3227-30.
Score: 0.005
-
Segment length and risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med. 2000 Nov 07; 133(9):747-8.
Score: 0.005
-
Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality. JAMA Netw Open. 2020 11 02; 3(11):e2023780.
Score: 0.005
-
Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes. Hepatology. 2020 10; 72(4):1242-1252.
Score: 0.005
-
Oral Health and the Altered Colonic Mucosa-Associated Gut Microbiota. Dig Dis Sci. 2021 09; 66(9):2981-2991.
Score: 0.005
-
Alcohol use alters the colonic mucosa-associated gut microbiota in humans. Nutr Res. 2020 11; 83:119-128.
Score: 0.005
-
The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2020 08 20; 26(9):1423-1428.
Score: 0.005
-
External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population. Dig Dis Sci. 2021 07; 66(7):2387-2393.
Score: 0.005
-
Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2021 07; 66(7):2439-2451.
Score: 0.005
-
Factors Associated With Delay of Diagnosis of Hepatocellular Carcinoma in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021 08; 19(8):1679-1687.
Score: 0.005
-
Spotlight: COVID-19 PPE and Endoscopy. Gastroenterology. 2020 Aug; 159(2):759.
Score: 0.005
-
Increasing Incidence of Advanced Non-cardia Gastric Cancers Among Younger Hispanics in the USA. Dig Dis Sci. 2021 05; 66(5):1669-1672.
Score: 0.005
-
Dietary Factors and Gastric Intestinal Metaplasia Risk Among US Veterans. Dig Dis Sci. 2021 05; 66(5):1600-1610.
Score: 0.005
-
Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure. J Hepatol. 2020 12; 73(6):1425-1433.
Score: 0.005
-
Letter: are microbes other than Helicobacter pylori associated with gastric cancer? Authors' reply. Aliment Pharmacol Ther. 2020 06; 51(12):1447-1449.
Score: 0.005
-
Systematic review with meta-analysis: prevalence of prior and concurrent Barrett's oesophagus in oesophageal adenocarcinoma patients. Aliment Pharmacol Ther. 2020 07; 52(1):20-36.
Score: 0.005
-
Gastric microbiota and Helicobacter pylori in Indonesian population. Helicobacter. 2020 Aug; 25(4):e12695.
Score: 0.005
-
AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19. Gastroenterology. 2020 Jul; 159(1):320-334.e27.
Score: 0.005
-
Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021 01; 19(1):61-71.e15.
Score: 0.005
-
AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic. Gastroenterology. 2020 Aug; 159(2):739-758.e4.
Score: 0.005
-
Burden of Pancreatic Cancer: From Epidemiology to Practice. Clin Gastroenterol Hepatol. 2021 05; 19(5):876-884.
Score: 0.005
-
Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. Am J Gastroenterol. 2020 03; 115(3):381-387.
Score: 0.005
-
Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis. Ann Intern Med. 2000 Feb 15; 132(4):261-9.
Score: 0.005
-
Effectiveness of Elbasvir/Grazoprevir in patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States veterans population. Antiviral Res. 2020 02; 174:104698.
Score: 0.005
-
Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients. Dig Dis Sci. 2020 09; 65(9):2691-2699.
Score: 0.005
-
Barrett's esophagus, hiatal hernia, and logistic regression analysis. Am J Gastroenterol. 1999 Dec; 94(12):3395-6.
Score: 0.005
-
Prevalence of Helicobacter pylori Positive Non-cardia Gastric Adenocarcinoma Is Low and Decreasing in a US Population. Dig Dis Sci. 2020 08; 65(8):2403-2411.
Score: 0.005
-
Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):88-94.
Score: 0.005
-
Reply to: "Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma". J Hepatol. 2019 12; 71(6):1262-1263.
Score: 0.004
-
Dietary quality and the colonic mucosa-associated gut microbiome in humans. Am J Clin Nutr. 2019 09 01; 110(3):701-712.
Score: 0.004
-
Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma. Cancer Res. 2019 09 01; 79(17):4326-4330.
Score: 0.004
-
Corpus gastritis is protective against reflux oesophagitis. Gut. 1999 Aug; 45(2):181-5.
Score: 0.004
-
Outcome of erosive reflux esophagitis after Nissen fundoplication. Am J Gastroenterol. 1999 Jul; 94(7):1771-6.
Score: 0.004
-
Recommendations for Successful Transition of Adolescents With Inflammatory Bowel Diseases to Adult Care. Clin Gastroenterol Hepatol. 2020 02; 18(2):276-289.e2.
Score: 0.004
-
Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents. Dig Dis Sci. 2019 11; 64(11):3328-3336.
Score: 0.004
-
Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol. 2019 07; 71(1):104-114.
Score: 0.004
-
Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey. J Viral Hepat. 2019 05; 26(5):596-602.
Score: 0.004
-
Dietary Nutrients Involved in One-Carbon Metabolism and Colonic Mucosa-Associated Gut Microbiome in Individuals with an Endoscopically Normal Colon. Nutrients. 2019 Mar 13; 11(3).
Score: 0.004
-
Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999 Mar 11; 340(10):745-50.
Score: 0.004
-
Ethnic variations in the occurrence of gastroesophageal cancers. J Clin Gastroenterol. 1999 Mar; 28(2):135-9.
Score: 0.004
-
Characteristics of intestinal metaplasia in the gastric cardia. Am J Gastroenterol. 1999 Mar; 94(3):622-7.
Score: 0.004
-
Clinical epidemiology and natural history of gastroesophageal reflux disease. Yale J Biol Med. 1999 Mar-Jun; 72(2-3):81-92.
Score: 0.004
-
A Prospective Targeted Serum Metabolomics Study of Pancreatic Cancer in Postmenopausal Women. Cancer Prev Res (Phila). 2019 04; 12(4):237-246.
Score: 0.004
-
Carbamazepine-associated severe bile duct injury. Am J Gastroenterol. 1999 Feb; 94(2):526-7.
Score: 0.004
-
Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization. Dig Dis Sci. 2019 06; 64(6):1470-1477.
Score: 0.004
-
Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA. J Hepatol. 2019 04; 70(4):639-647.
Score: 0.004
-
Missed Opportunities for Screening and Surveillance of Barrett's Esophagus in Veterans with Esophageal Adenocarcinoma. Dig Dis Sci. 2019 02; 64(2):367-372.
Score: 0.004
-
Opposing time trends of peptic ulcer and reflux disease. Gut. 1998 Sep; 43(3):327-33.
Score: 0.004
-
Prior Diagnosis of Barrett's Esophagus Is Infrequent, but Associated with Improved Esophageal Adenocarcinoma Survival. Dig Dis Sci. 2018 11; 63(11):3112-3119.
Score: 0.004
-
Elimination of Age-Associated Hepatic Steatosis and Correction of Aging Phenotype by Inhibition of cdk4-C/EBPa-p300 Axis. Cell Rep. 2018 08 07; 24(6):1597-1609.
Score: 0.004
-
Underuse of Surgery Accounts for Racial Disparities in Esophageal Cancer Survival Times: A Matched Cohort Study. Clin Gastroenterol Hepatol. 2019 03; 17(4):657-665.e13.
Score: 0.004
-
Real-world effectiveness of elbasvir/grazoprevir In HCV-infected patients in the US veterans affairs healthcare system. J Viral Hepat. 2018 11; 25(11):1270-1279.
Score: 0.004
-
Long-term follow up of patients with obscure gastrointestinal bleeding examined with video capsule endoscopy. Medicine (Baltimore). 2018 Jul; 97(29):e11429.
Score: 0.004
-
Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case-control study in US male veterans. Aliment Pharmacol Ther. 2018 08; 48(4):469-477.
Score: 0.004
-
The Association Between Statin Use After Diagnosis and Mortality Risk in Patients With Esophageal Cancer: A Retrospective Cohort Study of United States Veterans. Am J Gastroenterol. 2018 09; 113(9):1310.
Score: 0.004
-
Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation. Clin Gastroenterol Hepatol. 2019 01; 17(1):65-72.e5.
Score: 0.004
-
Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Am J Gastroenterol. 2018 08; 113(8):1148-1155.
Score: 0.004
-
Implementation of a Population-Based Cirrhosis Identification and Management System. Clin Gastroenterol Hepatol. 2018 08; 16(8):1182-1186.e2.
Score: 0.004
-
Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists. Dig Dis Sci. 2018 06; 63(6):1551-1557.
Score: 0.004
-
A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women. Cancer Med. 2018 05; 7(5):2180-2191.
Score: 0.004
-
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B. J Hepatol. 2018 08; 69(2):278-285.
Score: 0.004
-
Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population. Dig Dis Sci. 2018 05; 63(5):1173-1181.
Score: 0.004
-
Positive Predictive Value of International Classification of Diseases, 10th Revision, Codes for Cirrhosis and Its Related Complications. Clin Gastroenterol Hepatol. 2018 10; 16(10):1677-1678.
Score: 0.004
-
Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 08; 16(8):1220-1228.e4.
Score: 0.004
-
A research agenda for curing chronic hepatitis B virus infection. Hepatology. 2018 03; 67(3):1127-1131.
Score: 0.004
-
Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshop. Antiviral Res. 2018 02; 150:93-100.
Score: 0.004
-
Associations between different forms of gastro-oesophageal reflux disease. Gut. 1997 Nov; 41(5):594-9.
Score: 0.004
-
Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents. Aliment Pharmacol Ther. 2017 11; 46(10):992-1000.
Score: 0.004
-
Sleep Duration and Risk of Liver Cancer in Postmenopausal Women: The Women's Health Initiative Study. J Womens Health (Larchmt). 2017 12; 26(12):1270-1277.
Score: 0.004
-
Association Between Laparoscopic Antireflux Surgery and Recurrence of Gastroesophageal Reflux. JAMA. 2017 09 12; 318(10):939-946.
Score: 0.004
-
Anniversary Tribute From the Editors of Clinical Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2017 12; 15(12):1823-1827.
Score: 0.004
-
Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997 Sep; 113(3):755-60.
Score: 0.004
-
Mycobacterium avium complex esophagitis. Am J Gastroenterol. 1997 Sep; 92(9):1561-3.
Score: 0.004
-
Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2018 02; 16(2):252-259.
Score: 0.004
-
Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing. Dig Dis Sci. 2017 10; 62(10):2713-2718.
Score: 0.004
-
Hepatitis C virus-related complications are increasing in women veterans: A national cohort study. J Viral Hepat. 2017 11; 24(11):955-965.
Score: 0.004
-
Obesity and Risk of Nonalcoholic Fatty Liver Disease: A Comparison of Bioelectrical Impedance Analysis and Conventionally-Derived Anthropometric Measures. Clin Gastroenterol Hepatol. 2017 12; 15(12):1965-1967.
Score: 0.004
-
Gastric Cancer as Preventable Disease. Clin Gastroenterol Hepatol. 2017 Dec; 15(12):1833-1843.
Score: 0.004
-
Polymorphisms of 5-HTT LPR and GN?3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. Am J Gastroenterol. 2017 Jun; 112(6):903-909.
Score: 0.004
-
Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus. Eur J Cancer. 2017 04; 75:41-46.
Score: 0.004
-
Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2017 Aug; 15(8):1207-1217.e4.
Score: 0.004
-
Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists. Inflamm Bowel Dis. 2017 02; 23(2):254-260.
Score: 0.004
-
Menopausal hormone therapy and the risk of esophageal and gastric cancer. Int J Cancer. 2017 04 01; 140(7):1693-1699.
Score: 0.004
-
Economic aspects of endoscopic screening for intestinal precancerous conditions. Gastrointest Endosc Clin N Am. 1997 Jan; 7(1):165-84.
Score: 0.004
-
Association of esophagitis and esophageal strictures with diseases treated with nonsteroidal anti-inflammatory drugs. Am J Gastroenterol. 1997 Jan; 92(1):52-6.
Score: 0.004
-
Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One. 2016; 11(12):e0169250.
Score: 0.004
-
Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease. Dig Dis Sci. 2017 03; 62(3):607-614.
Score: 0.004
-
Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey. Dig Dis Sci. 2017 02; 62(2):526-533.
Score: 0.004
-
Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol. 2017 02; 14(2):122-132.
Score: 0.004
-
Acculturation and Nonalcoholic Fatty Liver Disease Risk Among Hispanics of Mexican Origin: Findings From the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol. 2017 02; 15(2):310-312.
Score: 0.004
-
Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. J Hepatol. 2017 02; 66(2):355-362.
Score: 0.004
-
Risk and Predictors of Variceal Bleeding in Cirrhosis Patients Receiving Primary Prophylaxis With Non-Selective Beta-Blockers. Am J Gastroenterol. 2016 12; 111(12):1778-1787.
Score: 0.004
-
Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV. Dig Dis Sci. 2017 01; 62(1):76-83.
Score: 0.004
-
Opportunities for Preventing Esophageal Adenocarcinoma. Cancer Prev Res (Phila). 2016 Nov; 9(11):828-834.
Score: 0.004
-
Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol. 2016 11; 111(11):1528-1535.
Score: 0.004
-
Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age. J Psychosom Res. 2016 09; 88:48-53.
Score: 0.004
-
Inverse Association Between Gluteofemoral Obesity and Risk of?Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol. 2016 10; 14(10):1412-1419.e3.
Score: 0.004
-
Weight Change and Weight Cycling Are?Not?Associated With Risk of Barrett's?Esophagus. Clin Gastroenterol Hepatol. 2016 12; 14(12):1839-1840.
Score: 0.004
-
Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus. Clin Infect Dis. 2016 08 01; 63(3):291-9.
Score: 0.004
-
A prospective study of soluble receptor for advanced glycation end-products and colorectal cancer risk in postmenopausal women. Cancer Epidemiol. 2016 06; 42:115-23.
Score: 0.004
-
Fulminant herpes colitis in a patient with Crohn's disease. J Clin Gastroenterol. 1996 Apr; 22(3):220-3.
Score: 0.004
-
Patient-Reported Attributions for Missed Colonoscopy Appointments in Two Large Healthcare Systems. Dig Dis Sci. 2016 07; 61(7):1853-61.
Score: 0.003
-
Validation of Case Finding Algorithms for Hepatocellular Cancer From Administrative Data and Electronic Health Records Using Natural Language Processing. Med Care. 2016 Feb; 54(2):e9-14.
Score: 0.003
-
Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer. Aliment Pharmacol Ther. 2016 Mar; 43(5):621-30.
Score: 0.003
-
Statins Are Underutilized in Patients with Nonalcoholic Fatty Liver Disease and Dyslipidemia. Dig Dis Sci. 2016 06; 61(6):1714-20.
Score: 0.003
-
Coffee or Tea, Hot or Cold, Are Not Associated With Risk of Barrett's Esophagus. Clin Gastroenterol Hepatol. 2016 May; 14(5):769-72.
Score: 0.003
-
Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett's Esophagus in Adults. Dig Dis Sci. 2016 Apr; 61(4):1139-47.
Score: 0.003
-
Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard. J Surg Res. 2016 Feb; 200(2):552-9.
Score: 0.003
-
Esophageal adenocarcinoma after obesity surgery in a population-based cohort study. Surg Obes Relat Dis. 2017 Jan; 13(1):28-34.
Score: 0.003
-
Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. Gastroenterology. 2015 Nov; 149(6):1599-606.
Score: 0.003
-
Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver?Disease: A Systematic Review. Clin Gastroenterol Hepatol. 2016 Feb; 14(2):191-202.e1-4; quiz e20.
Score: 0.003
-
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans is Associated With Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):124-31.e1.
Score: 0.003
-
Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Gastroenterology. 2015 Aug; 149(2):340-9.e2.
Score: 0.003
-
Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015 Jul; 149(1):119-29.
Score: 0.003
-
Physical activity and the risk of Barrett's esophagus. Dis Esophagus. 2016 Apr; 29(3):248-54.
Score: 0.003
-
Why send your paper to Gastroenterology: global outreach and partnerships with sister journals, CGH and CMGH, among a menu of offerings. Gastroenterology. 2015 Apr; 148(4):673-8.
Score: 0.003
-
Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans. Clin Gastroenterol Hepatol. 2015 Sep; 13(9):1616-24.
Score: 0.003
-
Reply: To PMID 24957400. Dig Dis Sci. 2015 Feb; 60(2):587.
Score: 0.003
-
Surveillance for hepatocellular carcinoma: can we focus on the mission? Clin Gastroenterol Hepatol. 2015 Apr; 13(4):805-7.
Score: 0.003
-
Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology. 2014 Dec; 60(6):1871-8.
Score: 0.003
-
Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification. Dig Dis Sci. 2014 Dec; 59(12):3103-10.
Score: 0.003
-
Nonalcoholic fatty liver disease (NAFLD) in the Veterans Administration population: development and validation of an algorithm for NAFLD using automated data. Aliment Pharmacol Ther. 2014 Oct; 40(8):949-54.
Score: 0.003
-
Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population. Clin Gastroenterol Hepatol. 2015 Mar; 13(3):594-601.e1.
Score: 0.003
-
The quality of care provided to patients with varices in the department of Veterans Affairs. Am J Gastroenterol. 2014 Jul; 109(7):934-40.
Score: 0.003
-
Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome. Dig Dis Sci. 2014 Dec; 59(12):2913-26.
Score: 0.003
-
Clinical and psychosocial variables associated with behavioral intentions to undergo surveillance endoscopy. BMC Gastroenterol. 2014 Jun 10; 14:107.
Score: 0.003
-
Nonalcoholic fatty liver disease is underrecognized in the primary care setting. Am J Gastroenterol. 2015 Jan; 110(1):10-4.
Score: 0.003
-
Accuracy of diagnostic codes for identifying patients with ulcerative colitis and Crohn's disease in the Veterans Affairs Health Care System. Dig Dis Sci. 2014 Oct; 59(10):2406-10.
Score: 0.003
-
Symptomatic reflux disease: the present, the past and the future. Gut. 2014 Jul; 63(7):1185-93.
Score: 0.003
-
Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J Clin Gastroenterol. 2014 Mar; 48(3):218-23.
Score: 0.003
-
Patient experiences with surveillance endoscopy: a qualitative study. Dig Dis Sci. 2014 Jul; 59(7):1378-85.
Score: 0.003
-
The impact of hepatitis C burden: an evidence-based approach. Aliment Pharmacol Ther. 2014 Mar; 39(5):518-31.
Score: 0.003
-
WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients. PLoS One. 2013; 8(12):e84407.
Score: 0.003
-
Response to Braillon. Am J Gastroenterol. 2013 Dec; 108(12):1931.
Score: 0.003
-
Limited life expectancy among a subgroup of medicare beneficiaries receiving screening colonoscopies. Clin Gastroenterol Hepatol. 2014 Mar; 12(3):443-450.e1.
Score: 0.003
-
The impact of HIV viral control on the incidence of HIV-associated anal cancer. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):631-8.
Score: 0.003
-
Association between facility characteristics and the process of care delivered to patients with hepatitis C virus infection. Dig Dis Sci. 2014 Feb; 59(2):273-81.
Score: 0.003
-
Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog. 2013 Nov; 52 Suppl 1:E139-47.
Score: 0.003
-
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013 Aug; 108(8):1314-21.
Score: 0.003
-
Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013 Nov; 11(11):1399-1412.e7.
Score: 0.003
-
Choosing Wisely and the perceived drivers of endoscopy use. Clin Gastroenterol Hepatol. 2013 Jul; 11(7):753-5.
Score: 0.003
-
Patients' intuitive judgments about surveillance endoscopy in Barrett's esophagus: a review and application to models of decision-making. Dis Esophagus. 2013 Sep-Oct; 26(7):682-9.
Score: 0.003
-
Esophageal eosinophilia after radiofrequency ablation for Barrett's esophagus. Dis Esophagus. 2013 Sep-Oct; 26(7):674-7.
Score: 0.003
-
Incidence and survival of colorectal cancer among Hispanics in the United States: a population-based study. Dig Dis Sci. 2013 Jul; 58(7):2052-60.
Score: 0.003
-
Process of care for hepatitis C infection is linked to treatment outcome and virologic response. Clin Gastroenterol Hepatol. 2012 Nov; 10(11):1270-1277.e3.
Score: 0.003
-
The performance of process measures in hepatitis C. Am J Gastroenterol. 2012 Oct; 107(10):1512-21.
Score: 0.003
-
Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012 Jul; 36(1):3-15.
Score: 0.003
-
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials. 2012 May; 33(3):523-33.
Score: 0.003
-
Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma. Br J Cancer. 2012 Feb 28; 106(5):1011-5.
Score: 0.003
-
Report on a single-topic conference on "Chronic viral hepatitis--strategies to improve effectiveness of screening and treatment". Hepatology. 2012 Jan; 55(1):307-15.
Score: 0.003
-
Barrett's esophagus: clinical features, obesity, and imaging. Ann N Y Acad Sci. 2011 Sep; 1232:36-52.
Score: 0.003
-
Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology. 2011 Aug; 54(2):463-71.
Score: 0.003
-
Increased risk of hepatocellular carcinoma after cholecystectomy. Br J Cancer. 2011 Jun 28; 105(1):154-6.
Score: 0.003
-
Inflammatory bowel disease characteristics and treatment in Hispanics and Caucasians. Dig Dis Sci. 2011 May; 56(5):1476-81.
Score: 0.002
-
Barrett's esophagus in children and adolescents without neurodevelopmental or tracheoesophageal abnormalities: a prospective study. Gastrointest Endosc. 2011 May; 73(5):875-80.
Score: 0.002
-
Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States. Hepatology. 2011 Mar; 53(3):737-45.
Score: 0.002
-
Hepatocellular carcinoma at the cutting edge of science and practice. Minerva Med. 2010 Dec; 101(6):391-3.
Score: 0.002
-
Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2010 Nov; 8(11):924-33; quiz e117.
Score: 0.002
-
An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010 Aug; 8(8):709-17.
Score: 0.002
-
Overview of the viral hepatitis problem. J Fam Pract. 2010 Apr; 59(4 Suppl):S11-6.
Score: 0.002
-
Determinants of medical system delay in the diagnosis of colorectal cancer within the Veteran Affairs Health System. Dig Dis Sci. 2010 May; 55(5):1434-41.
Score: 0.002
-
Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology. 2010 Feb; 138(2):513-21, 521.e1-6.
Score: 0.002
-
Medication usage and the risk of neoplasia in patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1299-304.
Score: 0.002
-
Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review. Am J Gastroenterol. 2009 Aug; 104(8):2100-9.
Score: 0.002
-
Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results. Am J Gastroenterol. 2009 Apr; 104(4):942-52.
Score: 0.002
-
Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study. J Pediatr Gastroenterol Nutr. 2008 Aug; 47(2):141-6.
Score: 0.002
-
The risk of hepatocellular carcinoma in patients with previous malignancy. Cancer Invest. 2008 Jun; 26(5):511-5.
Score: 0.002
-
Complications of pediatric colonoscopy: a five-year multicenter experience. Clin Gastroenterol Hepatol. 2008 May; 6(5):515-20.
Score: 0.002
-
Views of hepatitis C virus patients delayed from treatment for psychiatric reasons. J Viral Hepat. 2007 Dec; 14(12):883-9.
Score: 0.002
-
Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis. Gastrointest Endosc. 2008 Mar; 67(3):394-8.
Score: 0.002
-
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol. 2008 Jan; 103(1):120-7.
Score: 0.002
-
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007 Oct; 5(10):1221-8.
Score: 0.002
-
Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer. 2007 Aug 01; 110(3):660-9.
Score: 0.002
-
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007 May 09; 297(18):2010-7.
Score: 0.002
-
Cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident. Aliment Pharmacol Ther. 2007 Apr 15; 25(8):913-24.
Score: 0.002
-
Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. Clin Gastroenterol Hepatol. 2007 Apr; 5(4):508-12.
Score: 0.002
-
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol. 2007 May; 102(5):1016-21.
Score: 0.002
-
Complications of pediatric EGD: a 4-year experience in PEDS-CORI. Gastrointest Endosc. 2007 Feb; 65(2):213-21.
Score: 0.002
-
Adapting the Rx-Risk-V for mortality prediction in outpatient populations. Med Care. 2006 Aug; 44(8):793-7.
Score: 0.002
-
Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006 Mar; 130(3):639-49.
Score: 0.002
-
The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther. 2005 Nov 15; 22(10):1005-10.
Score: 0.002
-
Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl. 2005 Nov; 11(11):1370-8.
Score: 0.002
-
National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology. 2005 Oct; 129(4):1171-8.
Score: 0.002
-
Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005 May; 54(5):710-7.
Score: 0.002
-
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005 Mar; 128(3):620-6.
Score: 0.002
-
The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States. Aliment Pharmacol Ther. 2004 Aug 15; 20(4):445-50.
Score: 0.002
-
Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med. 2003 Apr 15; 138(8):627-33.
Score: 0.001
-
Outcomes of colorectal cancer in the United States: no change in survival (1986-1997). Am J Gastroenterol. 2003 Feb; 98(2):471-7.
Score: 0.001
-
The role of hepatitis C in hepatocellular carcinoma: a case control study among Egyptian patients. J Clin Gastroenterol. 2001 Aug; 33(2):123-6.
Score: 0.001
-
Celiac sprue among US military veterans: associated disorders and clinical manifestations. Dig Dis Sci. 1999 May; 44(5):966-72.
Score: 0.001
-
Empirical therapy versus diagnostic tests in gastroesophageal reflux disease: a medical decision analysis. Dig Dis Sci. 1998 May; 43(5):1001-8.
Score: 0.001
-
Colonic mucosal abnormalities associated with oral sodium phosphate solution. Gastrointest Endosc. 1996 May; 43(5):463-6.
Score: 0.001